ROIVW (Roivant Sciences) Total Equity: $5,292.41 Mil (As of Mar. 2026)


ROIVW Roivant Sciences Ltd ROIVW
55 GF Score
Price $2.75
! 7 Warning Signs
View Full Analysis

What is Roivant Sciences Total Equity?

Roivant Sciences ROIVW -3.85% 55 Total Equity is $5,292.41 Mil as of Mar. 2026. GuruFocus rates ROIVW with a GF Score™ of 55/100. The stock has 7 warning signs investors should review.

Roivant Sciences's total equity for the quarter that ended in Mar. 2026 was $5,292.41 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Roivant Sciences Total Equity Historical Data

* Premium members only.

The historical data trend for Roivant Sciences's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Roivant Sciences Total Equity Chart

Roivant Sciences Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial 2,061.43 1,607.59 6,448.53 5,187.20 5,292.41

Roivant Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,187.20 4,815.91 4,805.46 4,974.22 5,292.41
ROIVW
55GF Score
Roivant Sciences Ltd ROIVW
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Roivant Sciences Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Roivant Sciences's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=5708.687-416.275
=5,292.41

Roivant Sciences's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=5708.687-416.275
=5,292.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $5,292.41 Mil mean?
Roivant Sciences (ROIVW) has a Total Equity of $5,292.41 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Roivant Sciences and its competitors.
Is Roivant Sciences' Total Equity too high?
Roivant Sciences' current Total Equity is $5,292.41 Mil. Overall, Roivant Sciences has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does Roivant Sciences' Total Equity compare to INSM and INCY?
Roivant Sciences' Total Equity of $5,292.41 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Roivant Sciences and its competitors. Roivant Sciences's current Total Equity is $5,292.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Roivant Sciences stock overvalued right now?
Roivant Sciences (ROIVW) has a current Total Equity of $5,292.41 Mil. The current Total Equity is $5,292.41 Mil. Roivant Sciences' overall GF Score™ is 55/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Roivant Sciences (ROIVW), the current Total Equity is $5,292.41 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Roivant Sciences Business Description

Other Exchanges ROIV:USA87S:Germany
Address 50 Broadway, 7th Floor, London, GBR, SW1H 0BD
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
55GF Score

Get the complete analysis for ROIVW

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.75
Price